| 

Tallahassee
Office (Map/Directions)
3375-A Capital Circle N.E.
Tallahassee, Florida 32308
Toll Free: (877) ALL WE DO
Local Phone: (850) 553-HELP or
(850)
422-7773
Fax: (850) 422-3449
Contact Us
Key
West Office (Map/Directions)
608 Whitehead Street
Key West, Florida 33040
Toll Free: (877) ALL WE DO
Local Phone: (305) 294-4585
Fax: (305) 294-7822
Contact Us
Thomasville
Office (Map/Directions)
214 West Jackson Street
Thomasville, Georgia 31792
Toll Free: (877) ALL WE DO
Local Phone: (229) 226-HELP or
(229) 226-4357
Fax: (850) 422-3449
Contact Us
E-mail: lawyers@wrongfullyinjured.com
Disclaimer
Personal Injury Law...
It's All We Do! |
|
Archived Headlines
New England Journal of Medicine Recommends Not Prescribing Celebrex
(12/23/04)
Read
about Celebrex...
New
Worries About Drug Safety (Forbes.com, 12/16/04)
Read article...
UPDATE:
Pediatric Suicide Risk
Read
article ...
FDA
Health Advisory on Use of Antidepressants in Adults and Children
Read
article ...
Archived Celebrex Headlines
FDA:
Consider Alternative to Celebrex (CNN.com, 12/17/04)
FDA Researcher Blows Whistle on Merck
and Vioxx (11/18/04)
Archived
Crestor Headlines
FDA
Sends AstraZeneca Letter Over Crestor Advertisement (PharmaLive.com,
12/22/04)
Archived Vioxx Headlines
New Evidence Merck
Hid Vioxx Risk
(Business Week Online, 6/30/05)
"State
of Texas Sues Merck Over Vioxx
(Associated Press, 6/30/05)
Merck
tried to alter Vioxx in 2000
(MSNBC.com, 6/23/05)
Merck's
Vioxx lawsuits could reach 100,000
(MSNBC News, 5/23/05)
Despite
Safety Concerns Vioxx Aggressively Marketed
(MSNBC.com, 5/05/05)
Vioxx
aggressively marketed despite concerns
(MSNBC News, 5/5/05)
Vioxx
Costs Merck CEO His Job
(Yahoo.com, 5/5/05)
Judge
Sees Vioxx Lawsuit Lasting Rest of Decade
(Reuters, 4/28/05)
First
Wrongful Death Trial of Vioxx is Delayed
(1010
WINS.com NEW YORK , 4/28/05)
FDA
panel suggests warning labels for Vioxx
(The Johns Hopkins News-Letter, 3/4/05)
FDA
advisers had ties to painkillers' makers:
Without votes, Bextra and Vioxx would've been voted off market
(New York Times, 2/24/05)
Researchers
Confirm Vioxx Nearly Doubled Cardiovascular Risks In Cancer Prevention
Study (Science Daily, 2/23/05)
FDA
Official: Even Low-dose Vioxx Risky (MarketWatch, 2/17/05)
Merck
had early Vioxx warning? WSJ: Records show safety committee had
data showing users could develop heart problems in 4 months
Merck
Slumps On SEC Vioxx Investigation (Forbes, 1/28/05)
Vioxx,
Celebrex overprescribed? (USA Today, 1/25/05)
Journal
Releases Vioxx Study (CNN, 1/25/05)
FDA:
Scientist can publish controversial Vioxx safety data (AP, 1/4/05)
Merck
CEO to be deposed in Vioxx suits (CBS.MarketWatch.com, 12/28/04)
Pharmaceuticals
Face of the Year: David Graham (Forbes.com, 12/13/04)
Vioxx
Suit Filed in Phoenix on Behalf of Arizonans (The Associated Press,
12/11/04)
Vioxx
Users in Action Against Drug Company (12/10/04)
FDA Researcher Blow Whistle
on Merck and Vioxx (11/18/04)
FDA Failed
Public on Vioxx, Official Says (MSNBC, 11/18/04)
Merck
Preps Counter Offensive Over Vioxx (Forbes.com, 11/15/04)
The
Vioxx Safety Study Merck Didn't Do (Forbes.com, 11/12/04)
Merck
named in SEC, DOJ Vioxx probes (CNN Money, 11/8/04)
Vioxx
should have been withdrawn years ago: study (CBC Health and Science
News, 11/5/04)
Merck
Tried to Bury Vioxx Concerns for Years (Reuters, 11/1/04)
Merck's
Missing Vioxx Study (Forbes.com, 10/14/04)
Local
Firm May File Vioxx Suit (Tallahassee Democrat, 10/8/04)
FDA
Study Estimates Vioxx Linked to 27,000 Heart Attacks
(CNNMoney.com, October 6, 2004)
Vioxx
Questions and Answers from the
US Food and Drug Administration (9/30/04)
Coxibs and
Cardiovascular Disease (New England Journal of Medicine - PDF)
A
Statement From Public Citizen Concerning
the Withdrawal of Vioxx From the Market
FDA
Issues Public Health Advisory on Vioxx
as its Manufacturer Voluntarily Withdraws the Product
(Food and Drug Administration)
Merck
Withdraws Arthritis Drug Vioxx (USA Today)
Merck
To Withdraw Vioxx From Market Because of Heart Risks (Bloomberg)
J
U S T I C E
"Every single case we take is the most
important case that client will ever have and it is therefore
the most important case in our office."
Fonvielle Lewis Foote & Messer
© 2008 Fonvielle Lewis Foote & Messer
|